Publications
574
Citations
18,951
Est. group size
—
Recurring co-author estimate
Active years
46
Publishing since 1980
This researcher works in clinical medicine with a focus on kidney disease and its connections to cardiovascular and metabolic health. Recent work includes clinical trials of drug therapies (such as finerenone and vadadustat) for chronic kidney disease, type 2 diabetes, heart failure, and dialysis-related anemia. Note that the listed publications also include unrelated oncology and other topics, suggesting the record may mix multiple authors sharing this name.
Publication activity has been steady, running in the twenties to thirties per year over the past decade with an average of about 23 papers per year in the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
4 earlier awards
- NIH R01HL126903Dec 2015 – Dec 2023 · $608k awarded
ChLorthalidone In Chronic Kidney Disease (CLICK) Study
- NIH R01DK062030Jul 2003 – Feb 2015 · $314k awarded
Hypertension in Hemodialysis Patients
- NIH U01DK071633Apr 2007 – Mar 2013 · $331k awarded
Pathobiology of Kidney Disease: Role of Iron
- NIH M01RR000750Dec 1997 – Nov 1999 · $17k awarded
EFFECT OF SULFISOXAZOLE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF FUROSEMIDE
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~9 · 28% small-team papers (≤3 authors) · across 107 venues
- Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction
JACC Heart Failure · 2025
- Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease
Journal of the American College of Cardiology · 2025
- Inter‐organ crosstalk: The kidney's role in systemic health and disease
Journal of Internal Medicine · 2025
- Human-Centered Design and Iterative Refinement of Tools and Methods to Implement a Surveillance and Risk Prediction System for Clinical Deterioration in Ambulatory Cancer Care
ACI Open · 2025
- Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease
Diabetes Care · 2025
- Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes
Journal of the American College of Cardiology · 2025
- The presenting symptoms of patients with appendiceal malignant tumors.
Journal of Clinical Oncology · 2025
- S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Future Oncology · 2025
- End-of-life (EOL) outcomes and healthcare utilization for patients with hepatocellular carcinoma (HCC) who received immune checkpoint inhibition (ICI).
Journal of Clinical Oncology · 2025
- <b>Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of</b><b>Heart Failure and Chronic Kidney Disease</b>
2025
- <b>Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of</b><b>Heart Failure and Chronic Kidney Disease</b>
2025
- P043: STAN code 1.0: universal code to describe early BREAST CANCER
The Breast · 2025
- <b>Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of</b><b>Heart Failure and Chronic Kidney Disease</b>
2025
- Role of Artificial Intelligence in Green Banking Services in India
JOURNAL GLOBAL VALUES · 2025
- Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology Fellows
JCO Oncology Practice · 2025
- Journal of Clinical Oncology×20
- Nephrology Dialysis Transplantation×15
- Journal of the American Society of Nephrology×12
- Circulation×8
- Diabetes×8
- Arjun Sinha
Medicine · Indiana University
- K JAMERSON
Medicine · University of Michigan
- Sverre E. Kjeldsen
Medicine · University of Michigan
- James Brian Byrd
Medicine · Indiana University
- Kenneth Jamerson
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile